000 | 00961 a2200277 4500 | ||
---|---|---|---|
005 | 20250517130925.0 | ||
264 | 0 | _c20161221 | |
008 | 201612s 0 0 eng d | ||
022 | _a1533-4406 | ||
024 | 7 |
_a10.1056/NEJMc1612048 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _avan’t Veer, Laura J | |
245 | 0 | 0 |
_a70-Gene Signature in Early-Stage Breast Cancer. _h[electronic resource] |
260 |
_bThe New England journal of medicine _c12 2016 |
||
300 |
_a2200-2201 p. _bdigital |
||
500 | _aPublication Type: Letter; Comment | ||
650 | 0 | 4 | _aBreast Neoplasms |
650 | 0 | 4 | _aGene Expression Profiling |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aOligonucleotide Array Sequence Analysis |
650 | 0 | 4 | _aPrognosis |
700 | 1 | _aRutgers, Emiel J T | |
700 | 1 | _aPiccart, Martine | |
773 | 0 |
_tThe New England journal of medicine _gvol. 375 _gno. 22 _gp. 2200-2201 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1056/NEJMc1612048 _zAvailable from publisher's website |
999 |
_c26692823 _d26692823 |